DE69810340D1 - Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems - Google Patents

Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems

Info

Publication number
DE69810340D1
DE69810340D1 DE69810340T DE69810340T DE69810340D1 DE 69810340 D1 DE69810340 D1 DE 69810340D1 DE 69810340 T DE69810340 T DE 69810340T DE 69810340 T DE69810340 T DE 69810340T DE 69810340 D1 DE69810340 D1 DE 69810340D1
Authority
DE
Germany
Prior art keywords
treatment
naphtho
disruptions
imidazo
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69810340T
Other languages
English (en)
Other versions
DE69810340T2 (de
Inventor
B Reitz
J Mcnally
Pauline Sanfilippo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE69810340D1 publication Critical patent/DE69810340D1/de
Publication of DE69810340T2 publication Critical patent/DE69810340T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69810340T 1997-10-07 1998-10-05 Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems Expired - Fee Related DE69810340T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6123497P 1997-10-07 1997-10-07
PCT/US1998/020865 WO1999018104A1 (en) 1997-10-07 1998-10-05 Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders

Publications (2)

Publication Number Publication Date
DE69810340D1 true DE69810340D1 (de) 2003-01-30
DE69810340T2 DE69810340T2 (de) 2003-10-30

Family

ID=22034502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69810340T Expired - Fee Related DE69810340T2 (de) 1997-10-07 1998-10-05 Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems

Country Status (11)

Country Link
US (1) US6200984B1 (de)
EP (1) EP1025101B1 (de)
JP (1) JP2001519350A (de)
AT (1) ATE229953T1 (de)
AU (1) AU737177B2 (de)
CA (1) CA2305348A1 (de)
DE (1) DE69810340T2 (de)
DK (1) DK1025101T3 (de)
ES (1) ES2190112T3 (de)
PT (1) PT1025101E (de)
WO (1) WO1999018104A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008696D0 (en) 2000-04-07 2000-05-31 Merck Sharp & Dohme Therapeutic agents
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
DE60329415D1 (de) * 2002-12-06 2009-11-05 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
US7678474B2 (en) * 2005-07-22 2010-03-16 Lg Chem. Ltd. Imidazole derivatives and organic electronic device using the same
EP2469945A1 (de) 2010-12-23 2012-06-27 British Telecommunications public limited company WLAN-Lokalisierungsdienste
EP2472911A1 (de) 2010-12-29 2012-07-04 British Telecommunications Public Limited Company Proximitätsdienst für WLAN-Vorrichtung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69329654T2 (de) * 1992-08-19 2001-03-15 Mcneilab Inc 3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen
US5817668A (en) * 1996-10-07 1998-10-06 Ortho Pharmaceutical Corporation S-heteroatom containing alkyl substituted-3-oxo-pyrido 1,2-A!benzimidozole-4-carboxamide derivatives useful in treating central nervous system disorders

Also Published As

Publication number Publication date
CA2305348A1 (en) 1999-04-15
WO1999018104A1 (en) 1999-04-15
ES2190112T3 (es) 2003-07-16
ATE229953T1 (de) 2003-01-15
DE69810340T2 (de) 2003-10-30
JP2001519350A (ja) 2001-10-23
EP1025101B1 (de) 2002-12-18
EP1025101A1 (de) 2000-08-09
PT1025101E (pt) 2003-04-30
DK1025101T3 (da) 2003-04-07
US6200984B1 (en) 2001-03-13
AU737177B2 (en) 2001-08-09
AU9682798A (en) 1999-04-27

Similar Documents

Publication Publication Date Title
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
MY107157A (en) Quinuclidine derivatives.
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
KR900700486A (ko) 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법
CA2134964A1 (en) Bridged Aza-Bicyclic Derivatives as Substance P Antagonists
ATE223912T1 (de) Pyridylalkan-säureamide als cytostatika und immunosupressive arzneimittel
AP9701041A0 (en) Pyridylpyrrole compounds.
ATE182333T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
DE69716810T2 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物，包含該衍生物的藥物組合物以及製備該活性物質的方法
DE69810340T2 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
ATE417831T1 (de) Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
ATE209633T1 (de) Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ITMI920082A1 (it) Derivati solforati di acidi biliari
ATE124398T1 (de) 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung.
MY130771A (en) 3-azabicyclo [3.1.0] hexane derivatives useful in therapy.
TW367320B (en) Novel aryl compounds having CNS activity, process for their preparation and their use as medicaments
UA27738C2 (uk) 2,3,4,5,6,7-гексагідро-1-[4-[1-[4-(2метоксифеніл)піперазиніл]]-2-фенілбутирил]-1н-азепін або його фармацевтично прийнятна кислотно-адитивна сіль, що мають властивість пов'язувати рецептор 5нт1а, спосіб (варіанти) їх одержання, фармацевтична композиція
DE60003214D1 (de) Benz[f]indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee